SCHEMBL10070477

SCHEMBL10070477

COC1Oc2cc3c(O)cc(C(=O)O)c(-c4ccccc4)c3cc2O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.39
GPR35 Q9HC97 2/20 0.36
ACMSD Q8TDX5 3/20 0.36
HNF4A P41235 3/20 0.36
MCL1 Q07820 2/20 0.36
DHFR P00374 1/20 0.36
FABP3 P05413 1/20 0.34
FABP4 P15090 1/20 0.34
FABP5 Q01469 1/20 0.34
PTPN11 Q06124 2/20 0.33
PTPN22 Q9Y2R2 2/20 0.33
PTPRC P08575 1/20 0.33
PTPN9 P43378 1/20 0.33
PDE10A Q9Y233 1/20 0.33
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PDE4B Q07343 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041194 0.80 CYP19A1 (0.33) KDM4EMEN1KMT2APDE4BHSD17B10
SCHEMBL2018471 0.79 FABP3 (0.47) THRBGPR35ACMSDHNF4AMCL1
SCHEMBL1010666 0.76 ACMSD (0.46) THRBACMSDHNF4AMCL1DHFR
SCHEMBL10041201 0.74
SCHEMBL17733182 0.74 FABP3 (0.47) THRBFABP3FABP4KDM4EMEN1
SCHEMBL5754427 0.73 FABP4 (0.48) THRBGPR35FABP3FABP4FABP5
SCHEMBL4572102 0.73 THRB (0.45) THRBGPR35ACMSDHNF4AMCL1
SCHEMBL1009517 0.73 THRB (0.65) THRBGPR35ACMSDHNF4AMCL1
SCHEMBL9899175 0.72 SMN1; SMN2 (0.47) THRBACMSDHNF4AMCL1DHFR
SCHEMBL15492789 0.72 ACMSD (0.38) THRBGPR35ACMSDHNF4AMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120161089-A1 CHROMENE COMPOUND TOKUYAMA CORPORATION (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120161089-A1 CHROMENE COMPOUND CYP8B1, HSD3B2, CYP17A1 THRB 1392/4885GPR35 1537/4885ACMSD 3456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.